(Q39955576)

15 September 2017

1 reference

title

Immune Deficiency States Associated with Malignant Disease in Man (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

13 February 2023

author name string

J. Harris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4623010

13 February 2023

R. C. Bagai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4623010

13 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4623010

13 February 2023

publication date

1 March 1972

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:S0025712516324105?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

https://api.elsevier.com/content/article/PII:S0025712516324105?httpAccept=text/plain

13 February 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Medical Clinics of North America

13 February 2023

published in

1 reference

15 September 2017

volume

56

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

501-514

1 reference

Studies on delayed hypersensitivity in Hodgkin's disease

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Quantitative Estimation of the Reactivity of Normal and Hodgkin's Disease Lymphocytes with Thymidine-2-14C

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Antibody formation in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

effect of syngeneic and allogeneic plasma on lymphocytes from cancer patients, patients with non-neoplastic diseases, and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

PROLONGED SURVIVAL OF SKIN-GRAFTS FROM CANCER PATIENTS ON NORMAL RECIPIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Serum proteins in Hodgkin's disease and malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Lymphocytes in reticulum-cell sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Circulating antibodies in reticuloses

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Prolonged survival of a bone-marrow graft resulting in a blood-group chimera.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunologic Incompetence of the Neoplastic Lymphocyte in Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Long survival in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Burkitt's tumor in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

IMMUNOLOGICAL DEFICIENCY DISORDERS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND MULTIPLE MYELOMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Polymorphonuclear Leukocyte Myeloperoxidase Deficiency in a Patient with Myelomonocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Isolation and Characterization of RNA from Lymphocytes of Chronic Lymphocytic Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

ABNORMAL CELLULAR RESPONSE TO SKIN ABRASION IN CANCER PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Depression of immunologic reactivity of patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Bradykininogen levels in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Impaired immunologic reactivity and recurrence following cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Hypogammaglobulinaemia in chronic lymphatic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Combined Action of Phytohaemagglutinin and RNA on Lymphocytes from Patients with Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Globulin synthesis by human peripheral lymphocytes. In vitro measurements using lymphocytes from normals and patients with disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Lymphocyte response to P.H.A. in patients with non-lymphoid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Serum inhibitors of lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Effect of serum from cancer patients on homologous lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Lymphocyte response to phytohemagglutinin in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

[Delayed reaction of Hodgkin's disease lymphocytes to phytohemagglutinin]

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

PRODUCTION OF ANTIBODIES AGAINST VIRUSES IN LEUKAEMIA AND RELATED DISEASES

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Impaired in Vitro Lymphocyte Transformation in Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Studies of immunologic reactions of patients with Hodgkin's disease; antibody reaction to typhoid immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Suppression of the tuberculin response in malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunologic Response in Patients with Disseminated Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Serum gamma globulin levels in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Agammaglobulinemia and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

An investigation of Hodgkin's disease with respect to the problem of homotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunologic alterations in bronchogenic cancer. Sequential study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Quantitative antibody studies in man. III. Antibody response in leukemia and other malignant lymphomata

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immune responses in myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

The occurrence of abnormal serum proteins in patients with epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

CIRCULATING ANTIBODY RESPONSE IN MALIGNANT DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunological Studies in Kaposi's Sarcoma in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Serum immune globulin concentrations in acute leukemia during intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunoglobulin changes in disease: quantitation on the basis of heavy polypeptide chains, IgG (gammaG), IgA (gammaA), and IgM (gammaM), and of light polypeptide chains, type K (I) and type L (II)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Radiation-induced lymphocyte-immune deficiency. A factor in the increased visceral metastases and decreased hormonal responsiveness of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Effect of previous irradiation on the transformation of blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

The association of immune disease and malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunologic factors and resistance to infection in chronic lymphatic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Passive transfer of tuberculin sensitivity to patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

The Osmotic Fragility of Human Leucocytes in Normal and in Some Pathological Conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Antibody Deficiency in Macroglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Lymphocyte transformation in malignant lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunosuppressive effect of surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Studies on neutrophil function. II. Pathological aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

The local exudative cellular response in leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

QUANTITATIVE STUDIES OF THE LOCAL EXUDATIVE CELLULAR REACTION IN ACUTE LEUKEMIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Myeloma proteins (M-components) with antibody-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunoglobulin pattern in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

COMPARATIVE STUDY OF SKIN HOMOGRAFTS OF NORMAL DONORS AND DONORS WITH MALIGNANT NEOPLASIA IN A HOST WITH MALIGNANT DISEASE. A PRELIMINARY REPORT

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Hypogammaglobulinemia in Hodgkin's Disease Treated With Nitrogen Mustard

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Leukocyte function in patients with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunologic studies in the lymphoblastomas. II. The ability to develop an eczematous sensitization to a simple chemical and the ability to accept passive transfer antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ANTIBODY PRODUCTION IN MAN; A PRELIMARY REPORT

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Antibody response in hematologic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Cutaneous anergy and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

L-Asparaginase: Toxicity to Normal and Leukemic Human Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

The lymphocyte of chronic lymphatic leukemia.I. Electron microscopy–onset

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Lymphocyte number and response to phytohae- magglutinin in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Reticuloendothelial system phagocytic function in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Cytotoxic lymphocytes in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Response to bcg vaccination and survival in advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Homotransplantation of human cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Studies on lymphocytes. IX. The survival of atuotransfused labeled lymphocytes in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Catabolism of serum gamma G-globulins in a cancer patient and a normal volunteer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Effect of therapeutic irradiation on lymphocyte transformation in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Cytocidal action of colchicine in vitro on lymphocytes in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Heterogeneity of lymphocytes in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Lymphocyte response to phytohemagglutinin in Hodgkin's disease, lymphatic leukemia and lymphosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

The clinical implications of hypogammaglobul inemia in patients with chronic lymphocytic leukemia and lymphocytic lymphosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Reduced lymphocyte transformation in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Immunologic studies in Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Recurrent pneumonia in multiple myeloma and some observations on immunologic response

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932410-5

7 January 2021

Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy

5

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

A study of antibody formation in patients with malignant lymphomas

13 February 2023

46

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Ultramicroscopic studies of lymphocytes from cancer patients

13 February 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyanin

13 February 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

The Immunology of Malignant Disease

13 February 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Reactions obtained with transferred lymphocytes in patients with advanced cancer

13 February 2023

58

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Receptor sites for complement on certain human peripheral blood lymphocytes

13 February 2023

91

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Homologous and heterologous skin transplantation in patients with lymphomatous disease

13 February 2023

95

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Delayed hypersensitivity in cancer patients: cutaneous and in vitro lymphocyte response to specific antigens

13 February 2023

97

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

The association of hypogammaglobulinemia and chronic lymphatic leukemia

13 February 2023

109

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Chromatin and other cytologic indices in chronic lymphocytic leukemia

13 February 2023

129

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

The metabolic activities of leukocytes from lymphoproliferative and myeloproliferative disorders during phagocytosis

13 February 2023

131

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

The clinical picture of Hodgkin's disease

13 February 2023

156

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Lymphocytopenia: its causes and significance

13 February 2023

160

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

Immunologic studies in American patients with Burkitt-like lymphoma

13 February 2023

162

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32410-5

13 February 2023

Identifiers

0 references

1 reference